HIGHLIGHTS
- who: Glaucoma and colleagues from the Eye Center of Xiangya Hospital, Central South University, Changsha, China, Hunan Key Laboratory of Ophthalmology have published the article: From Bench to Bed: The Current Genome Editing Therapies for Glaucoma, in the Journal: (JOURNAL)
SUMMARY
Glaucoma is a group of optic neuropathies featured by degeneration of retinal ganglion cells (RGCs) and loss of their axons in the optic nerve (Jonas et_al, 2017). By 2020, there were an estimated 80 million glaucoma patients with approximately 11.2 million people being blind, making glaucoma a leading cause of irreversible . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.